Champions Oncology
CSBR
CSBR
29 hedge funds and large institutions have $35.6M invested in Champions Oncology in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.28% less ownership
Funds ownership: 42.85% → 42.57% (-0.28%)
4% less capital invested
Capital invested by funds: $37M → $35.6M (-$1.4M)
60% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 10
Holders
29
Holding in Top 10
1
Calls
$91K
Puts
$29K
Top Buyers
| 1 | +$19.4K | |
| 2 | +$15.1K | |
| 3 | +$6K | |
| 4 |
Renaissance Technologies
New York
|
+$5.59K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.18K |
Top Sellers
| 1 | -$178K | |
| 2 | -$97.2K | |
| 3 | -$70.7K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$47.4K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$37.3K |